Stay updated with breaking news from Cipla Acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharma major Cipla has generated considerable interest from private equity players. What makes it such an alluring prospect, and what does the future hold for this storied company? - Issue Date: Oct 29, 2023
Cipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute among the founders could potentially delay the deal until a consensus is reached on the valuation, according to sources cited by ET Now.
Kotak Institutional Equities found minimal portfolio overlap between Torrent Pharma and Cipla, thus limiting synergies
Torrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the company's talks to acquire a stake in Cipla. While the company did not deny the developments, it mentioned that it does not comment on speculative reports without verified data. Torrent Pharma is reportedly making efforts to secure financing for the acquisition.